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Subacromial spacer implantation
for massive rotator cuﬀ tears
Clinical outcome of arthroscopically treated
patients
There are several treatment options for
massive rotator cuﬀ tears (MRCT). Es-
pecially in elderly patients, conservative
treatment is often favored because of the
risks posed by anesthesia and surgery.
If massive tears have resulted in a cuﬀ
tear arthropathy with pseudoparalysis
of the aﬀected shoulder, a reverse total
shoulder arthroplasty is often the only
remaining treatment option. Younger
patients with reduced active external ro-
tation and abduction because of massive
posterosuperior cuﬀ tears and an intact
subscapularis tendon can beneﬁt from
a latissimus dorsi transfer [3].
Minimally invasive treatment options
are chosen in cases of a painful MRCT
in absence of a severely impaired func-
tion. Patients who cannot or do not
want to undergo extended open surgery
may beneﬁt from conventional arthro-
scopic treatment with a combination of
biceps tenotomy, cuﬀ debridement, syn-
ovectomy, bursectomy, and partial re-
pair or margin-convergence stitches. Of
course a complete repair should always
be performed, if possible. But the retear
rate ishigh[7]and failureswithpersistent
pain exist.
The InSpace Balloon (ISB®; Or-
thospace, Israel) is a new arthroscopic
treatment option that is used “on top”
of conventional arthroscopic treatments
for MRCT. It consists of poly-L-lac-
tide (PLLA), which is a biodegradable
synthetic material and is inﬂated with
a physiologic saline solution. PLLA is
not known to have toxic or tumorigenic
properties [11]. The inﬂated spacer re-
duces subacromial friction and extends
the space between the humeral head
and acromion and coracoacromial arch
[12]. It cannot reduce a static supe-
rior or anterosuperior migration of the
humeral head but it helps to keep the
humeral head centered during dynamic
movements. After cuﬀ repair or par-
tial repair the balloon reduces friction
forces and maintains the integrity of the
repaired cuﬀ [1]. The balloon deﬂates
after 10 weeks and the PLLA is resorbed
totally after 15 months.
TheISBhasbeencertiﬁed for the treat-
ment of MRCT in Europe since 2010.
While the number of implanted balloons
is rising, there is still a lack of data about
the clinical outcome. This study investi-
gates theclinical resultsofpatients treated
with conventional arthroscopic options
forMRCTandcompares themwith those
of patients who received an ISB “on top”
of conventional arthroscopic treatment.
The hypothesis was that even a poor
preoperative shoulder function can be
improved by both conventional arthro-
scopic techniques and the implantation
of an ISB.
Materials andmethods
This retrospective case-control study
comprised 23 Patients with an MRCT.
Patients were selected from the insti-
tutional database. The indication for
surgery was a painful loss of shoulder
function in the absence of osteoarthri-
tis, cranial migration of the humeral
head greater than type II according to
Hamada’s classiﬁcation, and cuﬀ tear
arthropathy.
In group A, 11 patients (female, n =
5, male, n = 6; mean age = 64.6 years)
were treated by a single surgeon under
general anesthesia in beach-chair posi-
tion with debridement of the rotator cuﬀ,
synovectomy, bursectomy, biceps teno-
tomy/tenodesis, and partial reconstruc-
tion of the rotator cuﬀ, if possible. Partial
reconstruction consisted of margin-con-
vergence stitches and/or medialized cuﬀ
repair with suture anchors.
Group B comprised 12 patients (fe-
male, n = 6, male, n = 6; mean age =
62.4 years) who received an ISB “on top”
of the debridement or partial reconstruc-
tion. The size of the ISB was determined
according to the intraoperative measure-
ment of the distance between the glenoid
rim and the most lateral aspect of the
major tubercle. A large size was im-
planted seven times while a medium size
was implanted ﬁve times. The small size
was not utilized. After the insertion of
the ISB under arthroscopic visualization
through a lateral portal, it was insuﬄated
with a physiologic saline solution. The
insuﬄated volume corresponded to the
manufacturer’s recommendations.
Two patients were excluded from the
study because their status had been con-
verted to a reverse total shoulder arthro-
plasty before follow-up. One of these
patients had been treated with an ISB
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Table 1 Tear patterns and techniques of partial reconstruction and treatment of the long head
of the biceps
GroupA (n = 11) Group B (n = 12)
Subscapularis (Lafosse) 5 (n = 1); 1 (n = 4); intact
(n = 6)
5 (n = 3); 2(n = 2); 1 (n = 2); intact
(n = 5)
Long head of biceps Torn (n = 4); partial tear (n = 7) Torn (n = 7); partial tear (n = 5)
Supraspinatus (Patte) 3 (n = 11) 3 (n = 12)
Infraspinatus (Patte) 3 (n = 10); 2 (n = 1) 3 (n = 10); 2 (n = 2)
Teres minor Intact (n = 11) Intact (n = 12)
Biceps tenotomy n = 4 n = 5
Biceps tenodesis n = 3 n = 0
Partial repair subscapularis n = 0 n = 2
Partial repair supraspinatus n = 1 n = 0
Partial repair Infraspinatus n = 4 n = 2
Margin convergence n = 3 n = 1
Table 2 Answers to questions on a four-point Likert scaleawith standard deviation (SD) of pa-
tients treated conventionally (group A) andpatientswho received anadditional InSpace Balloon
(group B)
Question Answers and SD on a four-point Likert scale
GroupA Group B
I would not undergo this type of surgery again 1.1 (0.3) 1.7 (1.2)
I was spared from amore invasive operation 3.7 (0.9) 3.6 (0.9)
My pain level was reduced 3.4 (1) 3.3 (1)
I am satisﬁedwith my clinical result 3.6 (1) 3.7 (0.7)
a1 I disagree, 2 I rather disagree, 3 I rather agree, 4 I agree
while the other had been treated con-
ventionally.
Preoperative shoulder function was
evaluated using the American Shoul-
der and Elbow Surgeons (ASES) and
the Constant scores. For follow-up, the
ASES and Constant scores were assessed.
The outcome of patients who underwent
conventional arthroscopic techniques
(group A) was evaluated after a mean
of 30.6 months. Patients treated with
a supplementary ISB (group B) un-
derwent two postoperative evaluations.
The ﬁrst was carried out after a mean
of 11.4 months and the second after
22.3 months. The shorter ﬁnal follow-up
of patients treated with an ISB occurred
because the ISB had not been available
earlier for treatments of MRCT in our
institution.
Additionally, all patients ﬁlled out
a questionnaire about their subjective
satisfaction based on a Likert scale.
The Medical University of Hannover,
Germany, provided ethical approval.
Data were analyzed with SPSS statis-
tics (IBM, version 22.0). Paired samples
were compared using Student’s t test for
paired samples in cases of normal dis-
tribution and with the Wilcoxon test in
other cases.
Results
The tear patterns and techniques of par-
tial reconstruction for the two groups
are described in. Table 1. An intraoper-
ative example of a partial reconstruction
in combination with an ISB is presented
in . Fig. 1a–c.
Preoperative shoulder function was
lower in patients treated with an ISB ac-
cording to the ASES score (group A: 59.1
andgroupB:31.5)and theConstant score
(group A: 60.7 and group B: 36.8).
At follow-up, both groups had an im-
proved shoulder function. Convention-
ally treated patients gained a mean of
29.5 points in the ASES score (p < 0.001)
and ameanof 16.9 points in theConstant
score (p < 0.001). Patients treated with
an ISB had a higher absolute improve-
ment in ASES score (54.2 points; p <
0.001) and Constant score (32.7 points;
p < 0.001). The absolute improvement
of clinical scores for both groups is illus-
trated in. Fig. 2. Twopatients of groupB
had a pseudoparalytic shoulder preoper-
atively (Constant score: 18 and 26). Post-
operatively their Constant score had im-
proved little (30 and 34, respectively).
The mean ASES score at follow-up
was 88.6 in group A and 85.7 in group B.
The mean Constant score was 77.6 in
group A and 69.5 in group B. Pre- and
postoperativeassessmentof theASESand
Constantscores issummarizedin. Fig. 3.
The additional investigation after
a mean of 11.4 months in group B
showed a further improvement of the
clinical results until the ﬁnal assessment
after 22.3 months (. Fig. 4).
Onafour-pointLikert scalepatientsof
bothgroupswere satisﬁedwith their clin-
ical outcome at follow-up (group A: 3.6
and group B: 3.7) and reported pain relief
(groupA: 3.5 andgroupB: 3.3). Theyalso
believed thatmore invasive treatmentop-
tionshadbeenavoidedbytheir individual
arthroscopic treatment (group A: 3.7 and
group B: 3.6; see . Table 2).
One patient who reported an increas-
ingly painful shoulder after 12 months
was examined with magnetic resonance
imaging (MRI). Besides the retracted ro-
tator cuﬀ tear, MRI showed remnants of
the deﬂated ISB, which had transformed
into scar tissue in the subacromial space
(. Fig. 5). The patient was treated con-
servatively.
Discussion
Toourknowledge, this is theﬁrststudyfo-
cusing on the clinical outcomeof patients
with MRCT who were treated arthro-
scopically with or without an additional
ISB.
The use of an ISB provided improved
shoulder function at follow-up. But con-
ventional arthroscopic treatment options
also lead to improved shoulder function.
Patients treated with an ISB had a higher
absolute improvement of clinical scores.
This ﬁnding occurred because of a lower
preoperative shoulder function. A pre-
sumablereasonforthe lowerpreoperative
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Abstract
Background. Massive rotator cuﬀ tears
(MRCT) can be treated arthroscopically by
partial reconstruction, tenotomy/tenodesis of
the long head of the biceps, and debridement.
A new treatment option is the additional
implantation of a biodegradable spacer
(InSpace Balloon®; ISB) into the subacromial
space, which reduces subacromial shear forces
to keep the humeral head centered in the
glenoid. The aim of this study is to investigate
the clinical outcome of patients with MRCT
who were treated arthroscopically with or
without an additional ISB.
Methods. The clinical outcome of patients
treated with conventional arthroscopic
techniques (n = 11, group A, partial repair,
biceps tenotomy, and debridement) and that
of patients treated with a supplementary ISB
(n = 12, group B) was retrospectively analyzed.
Preoperatively and postoperatively, shoulder
function was assessed with the Constant
and American Shoulder and Elbow Surgeons
(ASES) scores. At follow-up after a mean of
22 months, patients ﬁlled out a questionnaire
about their subjective satisfaction.
Results. Preoperative shoulder function was
lower in patients treated with an ISB (ASES
score: group A, 59.1; group B, 31.5; Constant
score: group A, 60.7; group B, 36.8). At follow-
up, both groups had improved shoulder
function (Constant score: group A, 60.7–77.6;
p < 0.001; group B, 36.8–69.5; p < 0.001; ASES
score: group A, 59.1–88.6; p < 0.001; group B,
31.5–85.7; p < 0.001). Patients in both groups
were subjectively satisﬁedwith their outcome.
Conclusion. The ISB is a feasible treatment
option for MRCT, providing subjective pain
relief and improved shoulder function. Further
studies with larger patient collectives and
longer follow-up are needed to conﬁrm
whether it is a safe and cost-eﬀective
treatment.
Keywords
Acromion · Shoulder · Cuﬀ, rotator ·
Debridement · Arthroscopic surgery
Implantation eines subakromialen Platzhalters bei Rotatorenmanschettenmassenruptur. Klinisches
Ergebnis arthroskopisch versorgter Patienten
Zusammenfassung
Hintergrund. Rotatorenmanschettenmassen-
rupturen (MRCT) können arthroskopisch durch
Partialrekonstruktion, Bizepssehnentenodese-
oder -tenotomie und ein Débridement the-
rapiert werden. Eine neue Behandlungsform
stellt die zusätzliche Implantation eines
resorbierbaren Platzhalters (InSpace Balloon®,
ISB) in den Subakromialraumdar. Dieser führt
zur Rezentrierung des Humeruskopfes und
zur Reduktion subakromialer Scherkräfte.
Ziel dieser Studie ist die Evaluation der
klinischen Ergebnisse arthroskopisch
therapierter Patientenmit MRCT mit oder
ohne zusätzlichen ISB.
Methoden. Retrospektiv wurden die
klinischen Ergebnisse konventionell-
arthroskopisch behandelter Patienten
(n = 11, Gruppe A, Partialrekonstruktion,
Bizepssehnentenotomie- oder tenodese
und Débridement) und von Patienten
mit zusätzlichem ISB (n = 12, Gruppe B)
untersucht.
Prä- und postoperativ wurde die Schulter-
funktion mittels Constant- und American-
Shoulder-and-Elbow-Surgeons(ASES)-Score
untersucht. Nach durchschnittlich 22Monaten
füllten die Patienten einen Fragebogen zur
subjektiven Patientenzufriedenheit aus.
Ergebnisse. Zum Nachuntersuchungszeit-
punkt wiesen beide Gruppen eine verbesserte
Schulterfunktion auf (Constant-Score in
Gruppe A: von 60,7 auf 77,6; p < 0,001;
Constant-Score in Gruppe B: von 36,8 auf
69,5; p < 0,001 und ASES-Score in Gruppe A:
von 59,1 auf 88,6; p < 0,001; ASES-Score in
Gruppe B: von 31,5 auf 85,7; p < 0,001). Die
absolute Verbesserung der Scores war für
Patientenmit einem ISB höher. Beide Gruppen
waren subjektiv mit dem Operationsergebnis
zufrieden.
Schlussfolgerung. Der ISB stellt eine
praktikable Therapieoption bei MRCT dar,
die mit subjektiver Schmerzlinderung und
verbesserter Schulterfunktion einhergeht.
Weitere Studien mit größeren Patientenkol-
lektiven und längerem Follow-up sind nötig,
um die Sicherheit und Kosteneﬃzienz dieser
Behandlung zu bestätigen.
Schlüsselwörter
Akromion · Schulter · Rotatorenmanschette ·
Débridement · Arthroskopischer Eingriﬀ
function is that the ISB was implanted
particularlyinpatientswhosemajorcom-
plaintwasheavypainandapoorshoulder
function. The indication for an arthro-
scopic treatment of MRCT was prob-
ably extended since the ISB was avail-
able. In two cases, the ISB was utilized
in pseudoparalytic shoulders. The af-
fected patients still had poor shoulder
function at follow-up. This ﬁnding con-
ﬁrms that a pseudoparalytic shoulder is
a contraindication for the implantation
of an ISB.
To date, the largest patient collective
(n = 20) treated with an ISB was pre-
sented by Senekovic et al. [13]. After
a 3-year follow-up they reported an im-
provement in the Constant score from
33.4 to 65.4 points. Pain relief was sus-
tained for the whole follow-up period.
Our patients treated with an ISB showed
a similar improvement in Constant score
from 36.8 to 69.5 points after 22 months.
These ﬁndings indicate that even a bad
preoperative shoulder function can be
improved by the implantation of an ISB.
Conventionally treated patients in our
study experienced a signiﬁcant improve-
ment in their aﬀected shoulder (Constant
score from 60.7 to 77.6; p < 0.001). Un-
fortunately, we did not assess the con-
ventionally treated group twice. It is
possible that further improvements af-
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ter 11 month are a general ﬁnding for
arthroscopic treatments of MRCT in the
absence of pseudoparalysis. Because of
the longer follow-up and the superior
preoperative function of conventionally
treated patients, the results cannot be
compared adequately with those of pa-
tients treated with an ISB. Still, the re-
sults of both groups at ﬁnal follow-up
demonstrate that conventional arthro-
scopic techniques lead to an improved
shoulder function, although the absolute
improvement was higher if an additional
ISB was implanted.
Porcellini et al. [10] described that
partial repair of the infraspinatus ten-
don in combination with an intact
subscapularis tendon and an irreparable
supraspinatus tendon could improve the
Constant score from 44 to 77 points after
a minimum follow-up of 5 years. This
result shows that partial repair should
always be conducted, if possible. In these
cases the additional implantation of an
ISB may not only protect the partial re-
pair but also improve shoulder function
by supporting the force couple of the
subscapularis and infraspinatus tendon.
The signiﬁcant improvement of clinical
scores in both of our groups is probably
related to the partial repairs conducted
(eight in group A and four in group B).
The lower number of partial repairs in
group B underlines that the rotator cuﬀ
was of a poorer quality and less mobile
in those patients. The ISB is probably
a reason for the highly improved shoul-
der function although partial repair was
conducted in only 33% of the patients.
The common sense that complete re-
pairsarebetter thanpartial repairs, which
are againbetter thanameredebridement,
has been proved by Moser et al. [9] and
Heuberer et al. [8]. The repair or partial
repair of MRCT leads to pain reduction
in over 80% of the patients [2, 5]. Even
a high rate of reversion of pseudoparal-
ysis for repairs of MRCT in the absence
of osteoarthritis has been described [4].
Since the ISB is supposed to reduce
friction forces and to maintain the in-
tegrity of the repaired cuﬀ [1], it may
support the healing of the tendon–bone
interface. This hypothesis could not be
proven by this study and should be in-
vestigated in further studies.
An arthroscopically assisted transfer
of the latissimus dorsi showed an im-
provement from 35.5 to 69.5 points [3].
The improvement is similar to that of
our patients treated with an ISB. But of
course these results cannot be compared
properly because these patients were fol-
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Fig. 28 Mean improvement of American Shoulder and ElbowSurgeons (ASES) score andConstant
score for conventionally treated patientswithmassive rotator cuﬀ tear (group A) andpatients treated
with an additional InSpace Balloon
Fig. 38 Mean values of preoperative (pre OP) and postoperative (FU) assessment of the American
ShoulderandElbowSurgeons score (ASES) andConstant score (CS) for conventionally treatedpatients
withmassive RCT (group A) andpatients treatedwith an additional InSpace Balloon
lowed up for a longer period and had
a severe preoperative external rotation
lag-sign. In these cases an ISB is not
indicated. However, if contraindications
exist for a latissimus transfer like in sub-
scapularis tendon tears, an ISB may be
an alternative treatment option.
Pain reduction has been reported [14]
for the ISB, as was shown in our study
with patients agreeing that their pain was
reduced (Likert scale 3.3/4). Conven-
tionally treated patients reported a sim-
ilar pain relief (3.4/4); therefore we can-
not state that pain reduction is a result
of the ISB. It is likely that bursectomy,
cuﬀ debridement, and biceps tenodesis
or tenotomy play a more important role
in pain relief. One patient treatedwith an
ISB complained of persistent pain. The
symptoms could be easedwith painmed-
ication and physiotherapy. Although the
MRI did not show a signiﬁcant bursi-
tis, a foreign body reaction might have
played a role in these symptoms.
Although a ﬂuoroscopy-guided im-
plantation of the ISB under local anes-
thesia has been described [6], we would
recommend a combination with conven-
tional arthroscopic techniques to treat
side pathologies such as bursitis, biceps
tendinitis, and debridement or cuﬀ re-
pair. Such a short arthroscopic interven-
tion does not require a long duration of
general anesthesia in contrast to reverse
total shoulder arthroplasty or complex
rotator cuﬀ repair. Therefore, the ISB
should be considered if patients suﬀer
from severe general diseases that do not
allow for a long duration of surgery.
This study showed a further improve-
ment of shoulder function between 11
and 22 months. The ISB degrades after
15 months. There is no exact explana-
tion for this ﬁnding. We assume that
a formation of scar tissue, as is presented
in . Fig. 4, may play a role. Another
theory why the outcome still improves
after degradation of the implant is an
improved muscle patterning of the force
couple between the internal and external
rotators, which is createdbya recentering
of the humeral had. Further studies need
to assess the sustainability of this eﬀect.
Reduced friction forces may decrease the
inﬂammatory component of an MRCT
and consecutive bursitis and synovitis.
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Fig. 48 Development of clinical results in patients treatedwith an InSpace Balloon.The American
ShoulderandElbowSurgeons score (ASES) andConstant score (CS) showed further improvementuntil
the ﬁnal follow-up
Fig. 58 This patientwas investigatedwithmagnetic resonance imaging (MRI) after 12months:The
MRI (T2, coronal plane) showed a deﬂated InSpace Balloon,which appears like a scar tissue formation
in the subacromial space (whitearrow)
Other arthroscopic treatment options
for MRCT such as allografts, synthetic
grafts, andxenograftshavenot yet proved
to be a superior treatment option, but
they should be considered as interposi-
tion scaﬀolds in cases of retracted tears
[15]. Whether a combinationwith an ISB
is feasible in those cases remains unclear.
Since the implantation of an ISB is not
demanding compared with other arthro-
scopic techniques for MRCT, the surgi-
cal eﬀort for an additional ISB is rather
low, while the costs are clearly higher.
This is why the implantation of an ISB
should be reserved for special indications
such as a very painful shoulder in ab-
sence of pseudoparalysis and fragile par-
tial repairs, which need to be protected
by a subacromial spacer that keeps the
reconstructed rotator cuﬀ attached to the
bony insertion.
Because of the low number of fol-
lowed-up patients, the authors cannot
recommend an uncritical use of the ISB
for MRCT. Further studies with larger
patient collectives need to assess mid-
term results and potential complications
such as foreign body reactions.
Limitations
Besides the low number of patients, this
study is retrospective. The diﬀerent pre-
operative ﬁndings and the diﬀerent fol-
low-up periods in the two groups do
not allow a comparison to be made be-
tween the presented groups. The range
of follow-up provides only short-term re-
sultsofaheterogeneouspatientcollective.
Furthermore, a selectionbiasbetweenthe
two groups exists, because the ISB was
implanted in patients with a signiﬁcantly
lower preoperative shoulder function.
Conclusion
The ISB is a feasible treatment option for
MRCT, which is not diﬃcult to perform
for experienced shoulder surgeons. Be-
side subjective pain relief, it provides im-
proved shoulder function, which further
increases after 1 ear. While even a low
preoperative shoulder function can be
improved through the implantation of an
ISB, a pseudoparalytic shoulder cannot
be restored. Further studies with larger
patient collectives and a longer follow-
up are needed to assess whether the ISB
is a safe and cost-eﬀective minimally in-
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